How SaaS CRM Technology Offers a Better AlternativeFor Pharma/Biotech Companies

The pharmaceutical industry is at the apex of major changes – from new government regulations to heightened consumerism and market saturation. Consequently, the entire industry is experiencing a strategic shift in all forms of operations including product development, marketing, sales management, and technology. One of the biggest shifts is in how companies are selling their products and the technologies used to support these sales processes. Outdated client/server systems still dominate the market but they are proving inadequate, expensive, and inflexible – sometimes serving more as a hindrance than a help. Pharmaceutical companies need sales management technology that is better, faster, and cheaper in order to pull out from their revenue slumps. Software as a Service (SaaS) is the answer. It’s a new way of delivering advanced sales-centric applications like the most popular type, customer relationship management (CRM) software. Because it is built on a multitenant architecture, SaaS technology allows software vendors to provide applications that are flexible, fast, specialized, and much less expensive to deploy and maintain. It’s the support that many of today’s pharmaceutical companies need. The following paper discusses the inherent problems facing the industry, defines SaaS in detail, and shows how this new technology can help pharmaceutical companies increase revenue and market share.

How SaaS CRM Technology Offers a Better AlternativeFor Pharma/Biotech Companies